DaVita Inc. (DVA) stock
DVANYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3042% below fair value
$173.00−1.22 (-0.70%)
Close on Nov 17, 2026Market cap $10.88BP/E 12.7Yield –
DaVita revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
DaVita's revenue for the twelve months ending Sep 30, 2026 was $14.17B, up 6.4% year over year. For fiscal 2025 it was $13.64B, up 6.5% from the year before. The highest annual figure on record is $13.64B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.64B | +6.5% |
| FY2024 | Dec 31, 2024 | $12.82B | +5.6% |
| FY2023 | Dec 31, 2023 | $12.14B | +4.6% |
| FY2022 | Dec 31, 2022 | $11.61B | -0.1% |
| FY2021 | Dec 31, 2021 | $11.62B | +0.6% |
| FY2020 | Dec 31, 2020 | $11.55B | +1.4% |
| FY2019 | Dec 31, 2019 | $11.39B | -0.1% |
| FY2018 | Dec 31, 2018 | $11.40B | +4.9% |
| FY2017 | Dec 31, 2017 | $10.88B | +1.6% |
| FY2016 | Dec 31, 2016 | $10.71B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.58B | +4.6% |
| Q2 FY2026 | Jun 30, 2026 | $3.55B | +5.2% |
| Q1 FY2026 | Mar 31, 2026 | $3.42B | +6.0% |
| Q4 FY2025 | Dec 31, 2025 | $3.62B | +9.9% |
| Q3 FY2025 | Sep 30, 2025 | $3.42B | +4.8% |
| Q2 FY2025 | Jun 30, 2025 | $3.38B | +6.1% |
| Q1 FY2025 | Mar 31, 2025 | $3.22B | +5.0% |
| Q4 FY2024 | Dec 31, 2024 | $3.29B | +4.7% |
| Q3 FY2024 | Sep 30, 2024 | $3.26B | +4.6% |
| Q2 FY2024 | Jun 30, 2024 | $3.19B | +6.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.07B | +6.9% |
| Q4 FY2023 | Dec 31, 2023 | $3.15B | +7.8% |
| Q3 FY2023 | Sep 30, 2023 | $3.12B | +5.9% |
| Q2 FY2023 | Jun 30, 2023 | $3.00B | +2.5% |
| Q1 FY2023 | Mar 31, 2023 | $2.87B | +2.0% |
| Q4 FY2022 | Dec 31, 2022 | $2.92B | -0.9% |
| Q3 FY2022 | Sep 30, 2022 | $2.95B | +0.4% |
| Q2 FY2022 | Jun 30, 2022 | $2.93B | +0.4% |
| Q1 FY2022 | Mar 31, 2022 | $2.82B | -0.1% |
| Q4 FY2021 | Dec 31, 2021 | $2.94B | +1.3% |
| Q3 FY2021 | Sep 30, 2021 | $2.94B | +0.5% |
| Q2 FY2021 | Jun 30, 2021 | $2.92B | +1.3% |
| Q1 FY2021 | Mar 31, 2021 | $2.82B | -0.7% |
| Q4 FY2020 | Dec 31, 2020 | $2.91B | +0.2% |
| Q3 FY2020 | Sep 30, 2020 | $2.92B | +0.7% |
| Q2 FY2020 | Jun 30, 2020 | $2.88B | +1.3% |
| Q1 FY2020 | Mar 31, 2020 | $2.84B | +3.6% |
| Q4 FY2019 | Dec 31, 2019 | $2.90B | +2.7% |
| Q3 FY2019 | Sep 30, 2019 | $2.90B | +2.0% |
| Q2 FY2019 | Jun 30, 2019 | $2.84B | -1.5% |
| Q1 FY2019 | Mar 31, 2019 | $2.74B | -3.7% |
| Q4 FY2018 | Dec 31, 2018 | $2.82B | +1.4% |
| Q3 FY2018 | Sep 30, 2018 | $2.85B | +3.0% |
| Q2 FY2018 | Jun 30, 2018 | $2.89B | +6.9% |
| Q1 FY2018 | Mar 31, 2018 | $2.85B | +8.3% |
| Q4 FY2017 | Dec 31, 2017 | $2.78B | – |
| Q3 FY2017 | Sep 30, 2017 | $2.77B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.70B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.63B | – |
See a number that looks wrong?